Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
6.27
-0.40 (-6.00%)
Mar 20, 2026, 3:40 PM EDT - Market open
Q32 Bio Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Q32 Bio stock has a target of 13, which predicts a 107.34% increase from the current stock price of 6.27.
Price Target: $13 (+107.34%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Q32 Bio is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +107.34% | Feb 25, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +139.23% | Mar 12, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $22 → $3 | Buy → Hold | Downgrades | $22 → $3 | -52.15% | Feb 11, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $20 → $4 | Buy → Hold | Downgrades | $20 → $4 | -36.20% | Feb 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $64 → $22 | Buy | Maintains | $64 → $22 | +250.88% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
n/a
from 53.74M
Revenue Next Year
n/a
EPS This Year
-2.63
from 2.42
EPS Next Year
-4.09
from -2.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -1.19 | -2.55 |
| Avg | -2.63 | -4.09 |
| Low | -3.99 | -5.02 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.